Prior to his position as President and CEO of Regentis Biomaterials , Ltd., Dr. Clemow served as President and Chief Executive Officer of Nexgen Spine Inc., which he joined in 2004. Dr. Clemow has more than 25 years of experience in the development and management of orthopaedic devices. He has served in numerous senior management positions including President& CEO of Gelifex, Inc.; Vice President of Worldwide New Business Development at Ethicon Endo-Surgery (a division of Johnson & Johnson); Vice President of New Business Development, Johnson and Johnson Professional Inc.; and Director of R&D, Johnson and Johnson Orthopaedics. Dr. Clemow holds B.Sc. and Ph.D. degrees in Metallurgy from the University of Surrey, and an MBA in Finance from Columbia University. Dr. Clemow is a Fellow of the American Institute for Medical and Biological Engineering and a Past President of the Society for Biomaterials from whom he was awarded the Hall Medal for Achievements in Biomaterials.

    Green Chemistry, Sustainability, renewable resources, biomass, biofuel, Green Engineering, green industrial applications, green investments, green process, green energy, biomaterials